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1. 
Introduction 
With the outbreak of plague in Yunnan province in 
China in 1884 and its subsequent spread to the international 
port of Hong Kong in 18941 the peoples of every continent 
might well have expected a devastating pandemic to overtake 
them. Little more could be done to stop the. spread of plague 
at this time than had been done in the London epidemic of 
1666 or even in the great pandemic of 1348 (23). The classi-
cal methods of plague prevention and control were based on 
the bel ief that plague was contagious. In the light of this, 
the three basic measures to be instituted were sanitation, 
quarantine and isolation. In spite of these precautions, 
plague epidemics in the past had run their natural course, 
dying out only when insufficient susceptibles remained to 
support thEill• With the threatening pandemic as stimulus 
and under the influence of the recent discoveries of Pasteur 
and Koch, the time was indeed ripe for the unraveling of the 
mysteries of the "black death". 
The two events which were to place the control of 
plague on a rational basis were the discovery of the causa-
tive agent by Yersin (58) and Kitasato (16) and the elabora-
tion by Simond (44) in 1898 of the relationship of the rat 
and rat flea to the spread of human bubonic plague. 
Although a detailed description of the epidemiologic 
control of plague is beyond the scope of this discussion, 
the contribution of Simond to the control of this di,sease 
cannot be overemphasized. The principles of rat and rat flea 
elimination developed by public health authorities in light 
of his findings, remain today the flrst line of defense 
against the epidemic spread of plague. 
There are still, however, several situations in which 
a basic immunity of the pop~lation is the most economic and 
practical way of preventing plague outbreaks. In some areas 
of the world as in Africa, India, Indonesia and China, where 
the population density is so high and the economic and social 
level so low as to prevent adequate rat and ectoparasite con-
trol, the only rational approach to the problem is mass immu" 
nization. 
The widespread nature o£ sylvatie plague among the 
wild rodents of central and southwestern Asia, southeastern 
Russia, South Africa and the western United States becomes 
more impressive every year. This great reservoir of poten-
tial infection demands the continuance of the strictest con-
trol o£ the urban rat population. Any disaster as war, 
floods, fire, etc., making efficient public health measures 
impossible, would open the way for plague spread from the 
hinterlands into the heavily populated regions. UDder such 
conditions a population of one hundred per cent susceptibles 
would offer a fertile field for epidemic plague. 
The epidemic of 1910 to 1911 in Manchuria (57), in 
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which 60 1 000 deaths due to pneumonic . plague were recorded, 
has been traced to the Tarabagan, a wild rodent of the Man-
churian plains. The primary case in this epidemic was bu-
bonic in nature, but rapidly progressed to a fatal pneumonic 
process. The most stringent rodent control will not be ef-
fective in preventing the person to person spread of pneumo-
nic plague. In the midst of this type or epidemic a high 
level of herd immunity would be a most effective weapon. 
That recovery from plague rendered an individual less 
susceptible to a second attack, has been observed for centu-
ries. This immunity is of relatively short duration and is 
not absolute, since reinfection has been recorded (23). With 
this knowledge available the search for an adequate plague 
prophylactic was rapidly undertaken after the discover, of 
the causative agent by Yersin and Kitasato. The vaccines 
which have been proposed or used since that time fall roughly 
into three categories: whole killed vaccines, vaccines of 
living avirulent bacilli and purified antigenic preparations. 
The Haffkine vaccine (11) is the most well known and 
most widely employed or all plague prophylactics. It might 
also be said to be the most controversial. Because of this 
"notoriety" it would be of value to discuss this preparation 
in some detail as an example of a "whole killed vaccine"• 
From its very inception the vaccine was severely cri-
ticized by the German workers. Frazer in 1900 found the 
supernatant of the vaccine to be non protective for the guinea 
pig. Haffkine had claimed that both the supernatant and the 
cell debri.s were of value. Kolle and Otto (17, 18) were in 
great doubt as to the protective value of any killed vaccine. 
The majority of the statistical studies carried out in India 
(Taylor (54)), on the other hand, attributed a high degree of 
protective power to the Haffkine prophylactic. These statis-
tics, however, have been attacked by Qtten (28) and other pro-
ponents of live vaccines, as subject to serious errors. In 
extensive field trials carried out in Java in 1921-1922, Otten 
reported a decrease in mortality rate of only 50 per cent in 
contrast to the six to ten fold decrease reported by the In-
dian workers • Sokhey ( 46) 1 however, expresses serious doubt 
as to the potency of the killed vaccine used by Otten in his 
tests, since most of it was not made at the Haffkine Institute 
and no details were given as to the method of preparation. 
The factors causing these wide differences of opinion are 
well summarized by Sokhey. What composes the Haffkine vaccine? 
How standard -is it? What strains of E• Restis were used in 
its manufacture? How was the virulence and antigenic potency 
of these strains maintained? 
The original method of preparation as proposed by Haft-
kine in 1897 was to grow a virulent plague strain in broth for 
six weeks at room temperature (26-29 C), kill with heat at 
70 C for one hour and preserve with halt per cent phenol. The 
5. 
length of incubation varied through the years from two weeks 
' 
to nine months; the temperature used in killing was modified 
by Haffkine in 1899 to 50-55 C for fifteen minutes and was 
changed again after his departure from the institute to 60-64 c. 
None of these modifications were experimentally tested (46). 
These details are reported here to give some indication 
of the problems involved in estimating the potency of a vac-
cine whiCh in itself has suffered such variation. 
In an excellent series of studies, Sokhey (45-51) sys-
tematically tested and controlled each of these variables. 
He found a 400 per cent error in the protection test used to 
estimate the potency of each batch of vaccine. After compara-
tive tests with the wild rat, guinea pig, white rat and the 
white mouse, Sokhey found the inbred white mouse of the Haft-
kine institute the most uniformly susceptible to plague inrec-
tione He did away with the use of the infected rat spleen for 
challenge and substituted broth grown organisms which could be 
accurately counted. With this test system available he found 
that a temperature over 55 C reduced the potency of the vaccine; 
that 27 C was optimum for growth and protective activityJ that 
virulence of individual strains could be maintained constant 
if stored at 4 C; that in the mouse, the supernatant of the 
vaccine was three hundred times more potent than the cell de-
bris; that if given in sufficient quantity the Haffkine pre-
paration will pr~teot guinea pigs. It is true that Sokhey waa 
trying to promote his vaccine, but the major! ty o£ his evi-
dence appears irre£utable. 
In comparative tests with virulent killed material and 
a living avirulent preparation, he £ound the killed vaccine 
one hundred and £i£ty times more e£fective. The validity o£ 
this observation must be seriously questioned. No studies as 
to the antigenic completeness of the avirulent strain used 
were carried out. It is possible that the variant had com-
s. 
pletely lost its protective ability as Schutze 1 s TRU strain 
(241 39) and would thus not be comparable to the EV or Tjiwidej 
strains o£ Otten (28) and Girard and Robie {8). The results 
of a series of well controlled studies reported by Meyer in 
! 
1948 are in general support of the e£ficacy o£ killed whole 
vaccines. Whether these preparations were killed with acetone, 
enloro£orm, heat, phenol, or alcohol, they were protective in 
mice, rats, guinea pigs and monkeys. 
The German Plague Commission suggested the use o£ an 
agar grown, heat killed preparation (6). This, of course, 
would greatly simplity the large-scale production o£ vaccine. 
During World War II the Cutter Laboratories produced an agar 
grown vaccine £or the Army which was killed and detox1£1ed 
with formalin and preserved in pnenolized saline. Several 
other types o£ killed vaccines (50), as the FrenCh lipo-
vaccine, the· A-D sugar vaccines proposed by the Russian workers, 
and the serum vaccine of the ~ster Institute have been tried 
on a small scale7but it is impossible to draw any conclusions 
as to t h eir efficacy from the small numbers of individuals 
involved (30). 
With any of these whole killed vaccines there are 
certain inherent difficulties in their application which must 
be recognized. Tb.e most important of these is the size of 
the antig~nic mass necessary to produce a usable immune res .. 
pons e. Meyer (23) states in this connection. "• • • it is 
the actual mass of bacterial protein rather than the method 
of preparing the dead antigens that controls the 1mmunasa-
toric effect." The actual mass required is in the range of 
36 billion to 60 billion organisms for a 60 kilo. man. To 
instill this number of organisms would require at least two 
or three doses wLth booster inoculations every six months. 
7. 
A one shot vaccine, a much sought after goal, is "biologically 
. 
not readily obtainable" (23). The difficulties arising from 
this need for a large antigenic stimulus are serious. Toxic 
reactions due to the Haffkine type vaccine are high~ producing 
in many casea1 fever• chills and marked local reactions. The 
need for revaccination every six months might lead to sensi-
tivity reactions of a serious nature. Submitting a native 
population to this type of inoculation more than once would 
be difficult indeed. 
In summary, it might be stated that although the majo-
rity of field trials with killed vaccines are subject to serious 
statistical errors, it is difficult to · avoid the impression 
from this data that these prophylactics are of some value. 
The results of laboratory studies using killed vaccines cer-
tainly indicate that if given in sufficient mass they are 
protective. Furthermore• there is no doubt that from a 
purely practical and economic point of view an efficient 
killed preparation would be very desirable. 
a. 
Soon after the discovery of the bacillus of peste, 
Yersin (58) observed that plague bacilli grown on peptone agar 
readily lost their virulence. He suggested the possibility 
of immunization with these attenuated strains. His preliminary 
experiments, however, were unsuccessful due to a residual ten-
dency to virulence remaining in the strains he employed. The 
first positive results were those of Kolle and Otto {17, 18) 
who screened a large number of strains attenuated spontaneously 
or by artificial means. Their best results were with a strain 
called Maasen V attenuated by growth at 40-41 C over a long 
period. They aChieved 72 and 35 per cent protection in guinea 
pigs and rats respectively. 
Several years later Strong {52, 53) achieved much bet-
ter results with this same strain by employing larger doses. 
He also perfor-med the first human inoculations with living 
avirulent plague bacilli. The two hundred individuals inocu-
lated suffered no ill effects, but the group was too small to 
dete~ine any protective values. 
The results of Girard and Robie (8, 9} in Madagascar 
and of Otten {28} in Java give striking evidence for the ef-
ficacy of living avirulent vaccines. Their results are sum-
marized below: 
vaccinated 
Girard 
unvaccinated 
vaccinated 
Otten 
unvaccinated 
Total 
46,879 
60,000 
37,435 
39,483 
Fatality Rate 
per thousand 
.47 
Both of these studies are of great significance as 
they are well controlled statisticallf. The failure of 
early workers to achieve protection in animal experiments 
was undoubtedly due to the use of strains which were no longer 
antigenically complete. Otten (28) and more recently Meyer 
(24) have tested a large number of avirulent strains in rats 
and guinea pigs and found several to be of no value at all 
and others to be protective for the guinea pig but not the 
rat. The reasons for this will become clear when the anti-
genic structure of the plague bacillus is discussed. 
As Otten (28) points out a single dose of living vac-
cine does not protec~ against aerogenic inteetion,and death 
from plague has been observed in individuals repeatedly vac-
cinated. None of this is surprising as we have already 
pointed out that recovery from infection does not leave a 
solid immunity. Nevertheless, the results of vaccination with 
living avirulent !• Restis are the best obtained to date. 
There are sound theoretical reasons in favor of living vac-
cines. The studies of Schfttze (39), Meyer (24), and Walker 
et al. (56) provide excellent evidence for this. Schfttze 
--
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showed that the ability to multiply within the host is of 
definite importance to the degree of antibody produced. The 
investigations of Meyer and Walker !! al. show that "infection" 
w1 th living avirulent plague strains proceeds in the same man-
ner as with the virulent bacilli. The great difference is that 
the pnagocytic cells of the spleen, liver and lymph nodes are 
capable of removing the avirulent organisms. Thus, the total 
antigenic mass received from a single inoculation with living 
avirulent bacilli is many times in excess of the actual mass 
given. Walker ~ !!• point out that although the actual de-
gree of multiplication could not be accurately determined, the 
inoculation of mice with 101 000 avirulent All22 resulted in a 
degree of protection comparable to that afforded by ten to 
twenty million killed organisms. 
On the other hand, the objections raised to the use of 
living vaccines are worthy of serious consideration. Chief 
among these is the maintenance of the vaccine in the fully 
antigenic, living state without contamination. Since the use 
of preservatives is of course eliminated, this presents a 
major obstacle in mass immunization. The possibility of re-
version to a virulent state has worried many investigators, 
but so far no serious difficulty has been encountered in this 
direction. 
11. 
The earliest attempt to isolate the protective antigen 
of plague was that of Lustig and Galeotti in 1900 (21, 22) 
Plague organisms were grown on agar and harvested in 
saline. The bacterial cells were centrifuged down 
and the paste suspended in .75 to 1.0% KOH. After 
extraction the alkali was neutralized with Oe5% acetic 
acid or dilute HCl, until a precipitate formed. This 
precipitate was filtered off, redissolved in o.s% so-
dium carbonate and dried. The final p:ro duct was found 
to be nucleo-protein in nature. 
The nucleoprotein extract proved to be antigenic and toxic, 
protecting mice, rabbits• guinea pigs and monkeys against in-
fection. On the basis of these results, the authors proposed 
this material be used in human immunization. Although no such 
trials were made, immune sera prepared in horses with this 
antigen ~oved to be of some curative value on a small number 
of patients. 
In an excellent series of investigations between 1910 
and ' 19141 Rowland (31-34) described the isolation of another 
nucleoprotein from !• ~estis. His method is outlined below. 
Four days growth of plague bacilli on nutrient agar 
was killed by the addition of chlorofo~ and then 
harvested in saline. The cells were washed two or 
three times in saline and the combined supernatants 
labelled Substance A. This material possessed variable 
toxicity and was of very slight protective value in the 
rat. The bacterial paste was ground in a mortar with 
Na2S04 (anhydrous) and then placed in an ice chest to 
freeze. The following day the mixture was dissolved 
at 37 C and then allowed to re-freeze. This procedure 
was repeated several times. Sufficient water was then 
added to make a saturated salt solution at 37 C and 
the precipitate was filtered off. After dissolution 
in water the material was filtered again. The filtrate 
(Substance B) was called the active nucleoprotein. 
This antigen was of great protective value in the rat 
while conferring no immunity to the guinea pig. 
Employing wet India ink smears and dark ground micro-
scopy, Rowland presented excellent evidence for the exis-
tence in f• pestis of a viscous, capsule-like material sur-
rounding each bacillary body. This structure was consis-
tently present in cells grown at 37 C and absent in those 
grown at 20 c. To distinguish this substance, possessing no 
definitely defined boundary and unstainable by the usual cap-
sular st~ins, from a true capsule, Rowland labelled it an 
envelope.. He believed that treatment of the cells w1 th his 
sulfation process modified the permeability of the envelope 
and eventually led to its solution. 
No serious investigations seem to have been undertaken 
after the work of Rowland to define the protective antigens 
of the plague bacillus until the reports of Sch~tze (35-39) 
in 1932. Morison, Naidu and Avari (27) in 1924 had shown 
that the protective and toxic activity of the Haffkine vac-
cine resided in the cell free supernatant, but they attempted 
no purification of these antigens. In 1932, Sch~tze repeated 
the morphologic studies of Rowland and succeeded in differ-
entiating between the envelope and somatic antigens on sero-
logic grounds. 
"Envelope antigen consists or the supernatant or a 
suspension or ~· pestis grown at 37 C (l slope or a 
2 day culture per cc or saline) centriruged arter 
heating to 60 c ror li hours. 
Somatic antigen consists or the supernatant or a 
suspension of B. pestis grown at 26 C (2 slopes of a 
3 day culture per co of saline) centrifuged after 
heating to 100 C for 1 hour." 
Envelope antigen was shown to be heat labile, losing its ability 
to produce antibody in the rabbit after steaming for one quarter 
hour and losing its ability to react !a vitro,as well,after 
steaming for one hour. Somatic antigen appeared to be perfect-
ly stable at these temperatures. 
Unfortunately, Sch!tze did not use his envelope and so-
matic antigens in protection . experiments, so no direct evidence 
is available as to their relative merits. However, he compiled 
a mass of data which leave no doubt that the envelope antigen 
is all important in rat and mouse protection. In 1939, after 
comparison of the envelope content and the protective ability 
of numerous virulent and avirulent strains, he showed that the 
protective value of a plague vaccine depends solely on the 
gmount of envelope antigen it contains. Completely unenveloped 
strains as TRU had no protective value whatsoever. He found 
that Harfkine type vaccines grown at 37 C produced more enve-
lope antigen and were better prophylactics ror the rat than 
those grown at 26 c. This difference could not be detected in 
the mouse, a situation which might explain why Sokhey was un-
able to confirm these results (see page 5). Schfttze concluded 
from this that some other antigen, produced equally well at 
37 C or 26 C, was also necessary in mouse protection. 
Kurauchi and Homma (19) reported the isolation of a 
fraction from !• pestis which they labelled the speci£ic 
immunizing fraction (SIF). They reported excellent protec-
tion o£ guinea pigs, mice, rats and monkeys, however, the 
complete lack of detail as to the methods used in the iso-
lation and purification of this antigen make it impossible 
to compare it with fractions of the plague bacillus isolated 
by other 'V'It>rkers. 
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Thus, up to 1940 it was known that the plague organism 
contained at least two antigens; the envelope antigen which 
appeared to be of great significance in mouse and rat protec-
tion and the somatic antigen, common to all plague and pseudo-
tuberculasis strains, which seemed of doubtful protective 
value. In 1947, Baker~ !!• (3, 4) reported the isolation 
and purification of the envelope antigens and opened the way 
for ccnclusive studies on the relative merits of the antigens 
of !• pestis as prophylactic agents. 
Acetone (•70 C) killed and dried plague bacilli were 
suspended in 2.5% NaCl and allowed to remain at room 
temperature for 24 hours. The bacterial cells were 
removed by· centrifugation at 15,000 rpm and reextracted 
with 2/3 the original volume of salt solution. The 
combined extracts were vacuum distilled (below 35 C) 
until concentrated three fold. Saturated (NHf)2so4 brought to pH 7.5 was used for the fractionat on 
procedures. The material brought down at .25 satura-
tion was found to be mostly agar and other media con~ 
stituents and was discarded. Fractions were then 
taken between .25 - .30 saturation {Fraction IA); 
.30 - .33 (Fraction IB); .40 - .6? saturation (Frac-
tion II). FIB was finally obtained as a pure crystal8 
line protein. FIA was found to be a ~otein polysaccha-
ride complex which could not be further broken down 
without destroying its biological properties. FII was 
highly toxic and thought to be the endotoxin of ~· pestis. 
No purification of this fraction was attempted. Fro~ 
the Chemical and serologic data on FIA and FIB it was 
thought that the protein constituents of both were 
identical. 
FIA and FIB appear identical by serologic analysis and are of 
equal protective ability in the mouse and monkey. 
The studies of Amies (2) are for the most part in com-
plete accord with the findings of Baker ~ al. 
Agar grown organisms 1 washed once in water were sus-
pended in distilled water to a concentration of 1% 
and an equal volume of M/1 KSCN was added. After ad-
justing the pH to ? .s with 10% KOH the mixture was 
stirred for 5 hours in a water bath at 37 c. The ex-
tract was cooled to room temperature~ adjusted to pH 
7.0, centrifuged, filtered through a Mandler candle 
and dialyzed until free of salt. Purification was 
carried out by repeated isoelectric precipitation at 
pH 4.4. The f1nal product so isolated and purified 
was found to be a simple protein of high immunogenic 
power for the mouse. 
Amies claimed~ however, that it was necessary to use solutions 
of high solubilizing effect on lyophilic coll.oida in order 
to remove the envelope of f• pestis. This discrepancy may be 
due to the fact that Baker et al. relied on serologic analysis 
to follow their extractions while Amies limited himself to mor-
phologic studies using the wet India ink method. Seal (401 
41) corroborates the findi ngs of Baker ~ al., stating that 
the active protein oan be dissolved by "merely suspending 
the organisms in distilled water." In any case, Amies' 
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preparation is serologically similar to Fraction I and is 
biologically of equal activi~. The studies of Seal extended 
the work started by Shrivastava (43) who found that the ac-
tive principle present in the supernatant of the Haffkine 
vaccine could be partially purified by salt fractionation. 
The difficulty in removing media constituents was overcome 
by Seal who employed a casein hydrolysate broth for cultiva-
tion of the bacilli. Unfortunately,seal did not -report any 
animal protection tests with his fractions~ but their chemi-
cal and serologic properties are closely allied to those of 
the fractions isolated by Baker et al. and Amies. 
12-15 liters of casein hydrolysate broth! pH 6.8, were 
placed in 4 liter Haffkine flasks in 1 1 ter amounts, 
inoculated with a 48 hour broth culture and incubated 
for 21-24 days at 28 c. The culture was passed through 
filter paper impregnated with .25% kieselguhr and then 
through a Seitz filter. The filtrate was neutralized 
with HCl to pH 7.2 and then fractionated with Na2S04• 
The following fractions were isolated: Pl/3 (33% 
saturated Na2S04); Pl/2-1/3 (a fraction taken between 
33% and 50% saturated Na2S04); Pl 1/2 (all material 
precipitating from 50% to saturation with Na2so4). The Pl/2 fraction was found to contain the serologi-
cally active fraction and the majority of it was pre-
cipitated in the Pl/3 fraction. This protein was not 
found in several pseudotuberculosis strains or in the 
unenveloped TRU strain of plague. 
I 
' 
A most disturbing aspect of immunization of mice with 
Fraction I is that on a weight basis the whole organism is 
just as efficient as the purified material. 
IMMUNOGENIC POTENCY OF FRACTIONS IN MICE 
PD5o 
FU 
F~ 
Whole bacilli 
1.3 u {.81 - 2.4) 
2.4 u (1.2 - 4.7) 
2.4 u (1.2 - 4.8) 
A comparative study was not carried out in rats. This may 
indicate, according to Baker ~ !l•, that the antigen has 
been degraded in the process of purification or that some 
other antigen · is needed in mous e protection. This is of 
great interest in the light of Schfttze 1s findings concerning 
the role of envelope antigen in mouse protection. He was 
unable to find any difference in protective power for mice 
between organisms grown at 26 C or those grown at 37 c. He 
came to the same conclusion as Baker et al., namely that 
~. 
some other antigen produced equally well at both temperatures 
must be of importance in the mouse. (See page 14). 
Immunization of man with Fraction I and subsequent sero-
logic analysis of their antibody response has been carried 
out by Meyer and Foster (25). In this particular test FI 
was "decidedly" more effective in producing mouse protective 
antibody than the Army formalin killed vaccine, avirulent 
living All22, or the avirulent strain Tjiwidej. This experi-
ment supplies striking evidence as to why it is of great 
advantage to use a purified, specific protective antigen in 
preference to the whole bacillus. Meyer and Foster state. 
"It should be noted that in this experiment 2.5 mgm of FI 
was given; this amount is contained in 15 billion or 7.5 
mgm of formalin killed organisms. Such dosage of partially 
detoxified plague bacilli induces severe local and systemic 
reactions, and cannot be administered in mass vaccinations 
against plague." 
From a review of these studies with purified antigens 
it is possible to get some insight into the role played by 
each in the dynamics of infection and resistance. Death in 
plague seems to be due to the elaboration by the bacilli of 
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a highly necrotizing endotoxin• This is strikingly demonstra-
ted by those cases of severe plague in the mouse bacteriologi-
cally cured by chemotherap,y, but still dying due to the libera-
tion of toxin from the dead bacilli (55). A review of the 
attempts to isolate and purify the plague toxin will not be 
entered into here. It should be recorded, however, that plague 
toxin differs from other endotoxins in its relative heat labi-
lity, its protein nature and the ease with which it can be 
isolated from the supernatant of fluid cultures. On the other 
hand• evidence presented by Englesberg (7) certainly indicates 
that this release of toxin into the media closely follows cell 
lysis and therefore defines this toxin as an integral part of 
the soma of the cell. As stated by Pollitzer (50), "•••••••• 
although there is no reason to revise the concept that the 
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plague toxin is an endotoxin, it will be noted that in this 
as in many other respects !• Restis shows peculiar features." 
From the beginning of plague research many workers have 
felt the necessity of including plague toxin in any proposed 
vaccine. Haffkine,as a matter of fact, checked the potency 
of each lot of vaccine by the febrile response it produced (54). 
The more recent work by Baker ~ al. and ~es has shown that 
the protective antigen is separate and distinct from the endo-
toxin. This is not altogether surprising. If the toxin of 
!• Restis is an endotoxin, its concentration in the tissues 
of an infected animal is directly proportional to the number 
of bacilli present. Multiplication then is the ~imary faot 
to be considered in the virulence of a given strain of plague. 
As stated by Jawetz and Mayer (14), "a virulent plague strain 
is one that will multiply greatly and finally bring about 
death of a given susceptible host animal when introduced in 
numbers not large enough to be toxic without multiplication." 
The defense of the host animal, therefore, must be directed 
against the multiplication of the bacilli and must be active 
before the organism has multiplied sufficiently to produce 
a lethal snount of toxin. 
The studies of Jawetz and Meyer (14) conclude that this 
defense is primarily a function of the macrophage system. 
Antibody in itself is not bactericidal, but in conjunction 
with pnagocytes it possesses considerable opsonic action. 
These workers also found some suggestion that the phagocytic 
cells of the iDDnune animal were more active than those of the 
normal, indicating the possibility of some tissue immunity. 
This point must be further clarified, however. 
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The Phenomenon of phagocytosis can be explained purely 
on the physical characteristics of the bacterial surface pre-
sented to the phagocyte. Thus, the presence of the slimy, 
viscous envelope on plague bacilli would render them very 
refractive to phagocytosis. The antigens isolated from this 
structure should, by this line of reasoning, produce antibody 
eapable of strong opsonic action and protective ability. This 
has proven to be the case in mice, rats and monkeys. Purified 
envelope antigen (Fraction I) is of very poor immunogenic 
value in the guinea pig. Baker (4) reported no consistent 
protection of the guinea pig at levels of 5 mgm of FI with or 
without adjuvant, and subsequent studies at the Hooper Founda-
tion (24 1 55) have failed to show any protection of the guinea 
pig with this antigen in doses of from 5 to 180 mgm. 
, 
Dieudonne and Otto (6) j~ 1912 did not take particular 
note of this refractoriness of guinea pigs to immunization, 
but vague references to this Phenomenon can be found in their 
summaries of individual investigations. Thus, Travel, Krumbein, 
and Glftcksmann {1902) using considerable amounts of culture 
material, produced short immunity in rats, but not in guinea 
pigs, where they were able only to prolong life. Jatta and 
Maggiora ran comparative tests on Haffkine vaccine, agar 
grown vaccine, and Lustig-Galeotti nucleoprotein, and found 
the immunizing action of all more marked in the rat than in 
the guinea pig. Kolle and Martini in 1902 noticed this same 
difference in passive protection tests with immune sera. 
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Rowland (31) was perhaps the first to investigate this prob• 
lem. He found that he could protect 100% of the guinea pigs 
immunized against plague with large doses of !• pseudotubercu-
losis while his nucleoprotein extract was of no vs.lue. All 
attempts to isolate this antigen from pseudotuberculosis bacilli 
failed. From this evidence Rowland concluded that the guinea 
pig and mouse protective antigens were qualitatively different. 
Otten (28) commented on the fact that among a large number of 
avirulent strains tested, the degree of envelope production 
varied inversely with their protective ability for guinea 
pigs and directly with their protective action for rats. He 
too came to the conclusion that the guinea pig required a 
qualitatively different antigen than the rat. These observa-
tions tie in very nicely ldth the observations of SchUtze (36, 
37) on the antigenic composition of the plague and pseudotu-
berculosis bacilli. He was able to demonstrate only two major 
antigens in plague: the envelope antigen specific for plague 
and the somatic antigen found in both plague and pseudotubercu-
losis. The serologic studies of Bhatnager (5) give ample con~ 
firmation to this work. 
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A few workers have reported protection of the guinea pig 
with whole and cell free antigenic preparations. Lustig and 
Galeotti (21) found their extracts protective, although, as 
discussed above, Jatta and Maggiora found this protection 
much more marked in the rat. Minervin ~ al. (26) were able 
to acbi~ve 50% protection with their A-D sugar vaccine. 
Kurauchi and Homma (19) reported excellent guinea pig protec-
tion using their ill defined extracts. Sokhey (45) was able 
to completely protect the guinea pig with the Haffkine vac-
cine. In none of these cases were the animal tests carried 
out on a large enough scale to be considered significant. 
A large number of experiments carried out at the Hooper 
Foundation (24 1 55) over a period of years has greatly clari-
fied the situation. With killed vaccines of any sort, the 
best protection possible appears to be in the range of 50 per 
oent. However, incorporation of these whole cell vaccines into 
alum or Freund type adjuvants increases their p~tective abili• 
ty for guinea pigs to 90 or 100 per cent. Using oil adjuvants, 
10 times washed bacilli (devoid of the bulk of envelope antigen) 
or the almost unenveloped strain 14 are excellent protective 
antigens. This would again tend to support the theory that 
the guinea pig antigen is qualitatively different than the rat 
antigen and that it lies within the soma of the bacillus. The 
observations of Otten concerning the relative merits of enveloped 
and unenveloped strains in the guinea pig and the rat have 
been confirmed and extended. Almost all avirulent plague 
strains protect guinea pigs excellently regardless of their 
envelope content. It is interesting to note that the strain 
TRU, definitely a plague strain by all criteria, is not pro-
tective for either the mouse or the guinea pig. This would 
indicate that the "guinea pig antigen" can also be lost in 
'dissociated strains of plague. 
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The use of purified envelope antigens, non-protective 
for the guinea pig, as prophylactics for mass immunization 
against plague certainly places great importance on this prob-
lem. The bulk of evidence indicates that man responds to 
plague antigens more like the mouse and monkey than the guinea 
pig. However, it would be of great theoretical and practical 
interest to establish this on more solid experimental grounds. 
The purpose of this investigation was to elucidate 
the chemical and serologic nature of the antigens of 
Pasteurella pestis found in the water insoluble residue 
of the bacilli and to determine the role of these antigens 
as prophylactic agents in the guinea pig. 
Materials and Methods 
I. Strains of Pasteurella pestis employed* 
A. Avirulent strains. 
All22 - This strain was obtained from the virulent 
plague strain 1084 isolated from an infected ground squirrel 
in San Benito County, California in 1939o The details of 
the isolation of the avirulent All22 variant are presented 
by Jawetz and Meyer (12). Strain All22 bas a well developed 
envelope producing as much Fraction I as many virulent 
strains. It is highly protective for both mice and guinea 
pigs (24). 
1! - !• 2estis strain 14 was also isolated b7 
Jawetz and Me~er (12) from the virulent plague strain 1084. 
This variant appears unenveloped by microscopic examination 
and contains less than .02% Fraction I by serologic analysiso 
Large doses of this strain are required to protect mice 
whereas it is highly immunogenic in the guinea pig. 
EV-76 - The variant used here was a transfer from 
the original avirulent strain isolated by Girard and Robie 
(8). It is extremely toxic, contains a fair ~ount of en-
velope antigen and is of high immunogenic value in both the 
mouse and the guinea pig. 
* All avirulent plague strains were obtained from the George 
Williams Hooper Foundation of the University of California. 
The virulent strains were only used in that phase of the 
work carried out at that institution. 
fo~ed. The antigens emulsified in oil were given intramus-
cularly in two equal doses one week apart. Antigens suspen-
ded in aqueous media were administered sUbcutaneously in two 
equal doses one week apart • . Twenty one days after the second 
dose a standard challenge dose of virulent f• pestis strain 
195/P was injected subcutaneously into the lower right quad-
rant of the abdominal wall. The challenge dose consisted 
of o.5 co of a lo-2 dilution of a 24 hour broth culture. 
Plate counts on blood agar were always carried out to deter-
mine the actual number of organisms given. This was invaria-
bly in the range of 1000 MLD (106 organisms). The positive 
controls for every experimen~ were either Cutter vaccine or 
Cutter residue. In oil adjuvant in amounts of .o5 mg these 
preparations will protect 80 to 100 per cent of the animals 
immunized. Ten times this amount in aqueous media will usu-
all7 protect no more than 50 per cent of the animals. The 
guinea pigs were observed for 30 days after challenge and 
all deaths confirmed as plague at autopsy. 
B. · Passive immunity. 
The serum to be tested was injected intraabdomi-
nally into the animals 24 or 2 hours before challenge. The 
same challenge and autopsy procedures were carried out as 
above. 
III. Production of Antisera in Rabbits 
The standard procedure with all antigens consisted of 
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one or more courses of intravenous injections. A course was 
composed of three injections given at 48-hour intervals, a 
five to seven day rest period, followed by another series of 
three injeetions. Seven days after the final injection a 
test bleeding was taken and if the sera proved satisfactory 
the animals were bled out. If the sera were poor, another 
course was given. Any deviation from this procedure will 
be discussed UDder Experimental Results. 
IV. Serologic Tests 
A. Qualitative precipitin test. 
This test was carried out in the conventional man-
ner using a standard serum dilution and serial dilutions of 
antigen layered over it. The tests were allowed to incubate 
for one to two hours at room temperature and then placed in 
the cold overnight. The following morning· the degree of pre-
cipitation in each tube was estimated and graded from ~ to 
-1- + -1- -1- • 
B. Selli~qus.nti tati ve precipitin tests. 
Two different procedures were employed to estimate 
by turbidimetric means the quantity of precipitate formed. 
The first method was the procedure described by Libby (20) 
employing the photronrefleotometer. The particular instru-
ment used was made by H. L. Baier of Rutgers University. 
With each serum preliminary tests were carried out to deter-
mine the concentration g1 ving maximum turbidity w1 thout pre-
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cipitation in 30 minutes at room temperature. When this had · 
been established, the unknown antigen was serially diluted 
in the desired range and 1 ml o~ each dilution added to the 
specially designed cuvettes. One ml of the predetermined 
serum dilution was added to each cuvette and the contents 
immediately mixed. After 30 minutes' incubation at room 
temperature the turbidities were estimated. This procedure 
according to L1bby,yields results which check very closely 
with quantitative precipitin data. 
When this instrument was not available, precipitin 
turbidities were estimated in a Klett-Summerson photoelectric 
colorimeter. The serum was diluted in such a manner that 
after two hours' incubation at room temperature the precipi-
tate formed gave a readable turbidity. The antigen to be 
tested was serially diluted in a series of 10 x 100 mm pyrex 
tubes with the ~inal volume being 1.0 ml. 1.0 ml o~ the 
chosen serum dilution was added and the tubes were immediate-
ly mixed. A~ter two hours' incubation at room temperature, 
1.0 ml o~ saline was added to each tube and the turbidities 
read in the photometer using a 420 mu filter. This procedure 
was foumd to give reproducible results, although no attempt 
was made to correlate these with quantitative precipitin 
determinations. 
c. ~uantitative precipitin analyses were carried out 
according to the method of Heidelberger and Kendall as des-
cribed by Kabat and Mayer (15). 
v. Casein Hydrolysate Mineral Glucose Media (CHMG) 
The development of this media for the growth of !• 
pestis was carried out by E. Englesberg (7). The composi-
tion of the media is outlined below. 
Casein Hydrolysate (Difco) 
CaC12 FeC13 JlgS04 
NH4Cl 
Glucose 
Phosphate buffer 
:30. 
The casein hydrolysate and mineral salts were made up to-
gether, neutralized with NaOH, dispensed in 222.5 m1 amounts 
in one liter wide mouth Erlenmeyer flasks and autoc1aved for 
20 minutes at 15 pounds pressure. The glucose was made up 
separately in 20% concentration, autoclaved for 15 minutes 
at 15 pounds pressure and added in 2.5 ml amounts to each 
flask. The phosphate buffer was made up in K/2 concentra-
tion and autoclaved for 15 minutes at 15 pounds pressure. 
25 ml of the concentrated buffer were then added to each 
of the Erlenmeyer flasks. 
VI. The Preparation of Fraction I 
The Fraction I used in this work was prepared according 
to the method of Baker~ !l• (4). !• pestis strain Yreka 
was used as the source of the antigen. In all cases, the 
fraction used was the carbohydrate containing Fraction IA 
and will be referred to as Fraction I. 
VII. Cutter Residue 
The so-called "Cutter residue" was obtained from the 
George Williams Hooper Foundation, University of California. 
The Cutter Laboratories prepared a large amount of Fraction 
I froml• pestis strain Yreka. They extracted the agar grown 
organisms twice with 2e5% NaCl a•eording to the method of 
Baker!!~· (4),and the residue from these extractions was 
frozen. After thawing this material,it was extracted three 
times with 2.5% NaCl, washed two times in saline and dried 
from acetone. The dried powder will be referred to as 
Cutter residue or residue. 
VIII. Chemical and Physical Analyses 
1. Nitrogen determinations were carried out according 
to the micro-Kjeldahl method described by Kabat and Mayer (15). 
2. Phospnorus analyses were carried out following the 
method of Allen (1). 
3. The Shaffer-Somogyi modification of the Shaffer• 
Hartman method was followed for reducing sugar determinations 
(42). 
4. The procedure described by Kabat and Mayer (15) 
was employed for glucosamine determinations. 
5. Electrophoretic analyses were done by Dr. M. A. 
Derow and Dr. M. M. Davison of Boston University using a 
Perkin-Elmer tiselius apparatus. 
6. Ultraviolet spectra were determined using a Beckaan 
Quartz Spectrophotometer, Model DU. 
Experimental Results 
Qualitative Serologic Analysis 
Since the use of animal protection tests to determine 
the efficacy o~ a given antigenic preparation was too long 
and cumbersome £or routine purposes, it seemed advisable to 
compare different preparations by serologic methods. Plague 
antisera were produced in rabbits with living avirulent P. 
pestis strain All221 using a minimum of three courses of 
immunization (18 injections). This long, intensive immuni-
zation was assumed to produce sera containing antibody against 
even the minor plague antigens·. It was further assumed that 
the absorption of these sera with Fraction I (envelope anti-
gen) would leave antibody directed against the somatic anti-
gens of the plague bacillus. Thus, for routine analysis of 
all antigenic preparations, qualitative precipitin teste 
using these hyperimmune All22 rabbit sera, absorbed and unab-
sorbed were employed. 
Diethylene Glycol, Pyridine and Glycerol Extracts 
At the outset of this investigation it was thought that 
the plague bacillus might contain a somatic antigen similar 
to the somatic antigens of the Gram negative enteric group. 
The method commonly employed to extract these antigens from 
the shigellae and the salmonellae were investigated. Extrac-
tion of Cutter residue with 50% aqueous diethylene glycol, 
100% diethylene glycol, glycerol and 50% aqueous pyridine was 
carried out in the same manner and will be described together. 
The dried Cutter residue was suspended in 3 to 5 per 
cent concentration in the above solvents and extraction al-
lowed to proceed for 24 hours .at room temperature. The in-
soluble material was separated by centrifugation at 10,000 
rpm for 30 minutes in a Servall angle centrifuge, Model SSIA, 
the supernatant dialyzed against distilled water in the cold 
(3 C ~ 2) and lyophilized. 
The diethylene glycol and glycerol extracts contained 
only a trace of antigenic material which was primarily com-
posed of envelope antigen. Because of this poor serologic 
reactivity no animal tests were undertaken. 
Extraction with 50% aqueous pyridine on the other hand, 
removed some 15 per cent of the dry weight of the residue. 
This extract also contained a large amount of envelope anti-
gen, but reacted sufficiently well with absorbed All22 serum 
to warrant testing in animals. The results of the serologic 
tests are presented below. 
Antigen Dilution (in thousands) 
Serum 1 5 25 
·All22 
-1--1--1--1- -1--1--1--1- -1--1--1-
All22 ab-
sorbed with 
Fraction I -/-;L-1-+ 
-I--I-+ 
125 250 Control 
-
-
The results of the guinea pig protection tests (Table I) 
show that this extract when incorporated in adjuvant was pro-
tective for guinea pigs only when administered in relatively 
large amounts (5 mg). Since it has been well established that 
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the residue will regularly protect 80 to 100 per cent of the 
guinea pigs immunized when given in doses of o.os mg, it was 
apparent that the pyridine .extract could only contain a small 
amount of the protective antigen. All attempts to concen-
trate this active principle in the crude extract by fractiona-
tion with acetone were unsuccessful. 
The Phenol Antigen 
It was clear at this point that the guinea pig protec-
tive material present in the residue was tenaciously held 
to the soma of the bacillus and that more drastic methods of 
extraction would be required to liberate it. A modification 
of the method employed by Palmer and Gerlough (29) to extract 
the somatic antigen of Salmonella tyPQ! was tried in an at-
tempt to disrupt this complex. 
Residue was suspended in 3 to 5 per cent concentration 
in 90% aqueous Phenol (90 per cent by volume) and extraction 
continued at room temperature for 24 hours. Three volumes of 
95% ethanol were added with agitation and the entire mixture 
was dialyzed against distilled water until free of solvents. 
In subsequent experiments only the precipitate formed by the 
addition of ethanol to the 90% pnenol extract was dialyzed. 
This procedure greatly reduced the volume, facilitating 
handling and recovery, and yielded identical results. After 
dialysis the insoluble material remaining in the dialyzing 
membranes was removed by centrifugation and dried from ace-
tone. This fraction will be referred to as "phenol residue". 
The material in solution was concentrated by perevaporation 
at room temperature and lyopbilized. This fraction will be 
referred to as "crude phenol antigen". 
Experiments were carried out to determine the optimum 
time of extraction with Phenol for maximum yield of crude 
pnenol antigen. Six grams of residue were extracted for 6, 
12~ 24 and 48 hours and the remainder of the procedure carried 
out as above. The yields are presented below. 
Time Extracted Yield Per Cent of Residue 
6 hours 238 mg 3.97 
12 hours 332 mg 5.54 
24 hours 220 mg 3.77 
48 hours 324 mg 5.4 
Since no consistent trend could be determined. from 
these results, the final yield varying from 4 to 5.5 per eent 
of the dr7 weight of the Cutter residue, it was decided to 
continue the original procedure of extracting for 24 hours. 
The activity of the crude Phenol extract against Frac-
tion I absorbed All22 serum indicated that this material con-
tained a large ~ount of somatic antigen. The results are 
presented below. 
Antigen Dilution (in thousands) 
Serum 1 2 10 50 250 Control 
All22 
-1--1--1--1- -1--1--1--1- . -1--1--1--1- -1--1--1- :i: 
All22 Ab-
sorbed with 
Fraction 
I 
-1-+-1--1- +-1--1--1- -1-+-1- +-I- ....,. 
-
Although the precipitate formed with crude Phenol anti-
gen and plague antisera was heavy after 24 hours, the system was 
a very slow one, taking several hours for a heavy turbidity to 
develop. The exact significance of this was not determined. 
To remove the small amount of envelope antigen contained 
by the crude phenol extract, fractionation with acetone in 
the cold (3 C ~ 2) was carried out. The bulk (40 to 60 per 
cent) of the serologically active material present precipi-
tated from 0.15 M NaCl at 33% acetone concentration. The 
fraction precipitating between 33 to 55% acetone was small 
(10 to 15 per cent) and contained the majority of the enve-
lope antigen. After three reprecipitat1ons at 33% acetone 
the Phenol antigen no longer reacted with Fraction I antibody 
and was considered sufficiently pure for Chemical analysis. 
The purified Phenol antigen was essentially electro-
pnoretically homogeneous (Figure 1} in veronal buffer, pH 
8.6 and ionic strength 0.10. A small second component only 
present in the ascending boundary was estimated to compose 
no more than 3 per cent of the antigen. The analytic data 
presented in Table II suggest that this material is a car-
bohydrate-protein complex. No significant amount of nucleic 
acid could be detected in the ultraviolet absorption spec-
trum (Figure 2). 
The phenol antigen proved to be of excellent immuno8 
genic quality in rabbits, a single course of immunization 
(six injections) using a total antigenic stimulus of 20 mg 
producing sera with 0.45 mg of antibody nitrogen per ml (Fig-
ure 3 1 Table III). The quantitative serologic data presented 
are typical of a single antigen and its homologous antibody 
and add further proof as to the relative purity of the material. 
On the basis of these data, guinea pig protection tests 
were undertaken. The compiled results of a se~es of such 
tests are presented in Table IV. It was apparent from the re-
sults of these tests that the purified Phenol antigen was de-
void of prophylactic activity against plague in the guinea 
pig. It was also clear that treatment with phenol markedly 
reduced the protective quality of the residue as is evidenced 
by the poor protective quality of the phenol residue. 
The possibility that the Phenol antigen in conjunction 
with Fraction I was necessary for guinea pig protection was 
also submitted to test. The results (Table IV) were i~conclu­
sive, with the maximum protection obtained in the relatively 
high total dose of 5 mg (2.5 mg of each antigen) being 50 per 
cent. The significance of this level of protection on only 
six animals is doubtful. Further experiments to confir.m these 
findings were not undertaken as more promising results were 
obtained with other antigenic preparations. 
Since specific chemical extractants seemed of little 
value in solubilizing the "guinea pig antigen", physical meth8 
ods were employed to break up the bacillus. The first method 
to be investigated was sonic disruption. 
Sonic Lysates* 
Vibration of residue at 10,000 kilocycles per second 
for four hours resulted in almost complete lysis of the 
bacilli. The degree of disruption during vibration was fol-
lowed by microscopic examination. When lysis had progressed 
sufficiently, the cell debris was removed by centrifugation 
at 10,000 rpa and the supernatant was dialyzed and lyophilized. 
This procedure was carried out on agar grown~ acetone dried 
!• pestis strain EV-76 as well. The material released into 
solution contained a large amount of somatic material (see 
below) and was protective for guinea pigs in amounts of 
.os mg (Table I). 
Antigen Dilution (in thousands) 
Serum 10 50 250 1250 Control 
All22 
-1--1--1--1- -1--1--1--1- ++ - -
All22 Ab-
sorbed 
with Frac-
tion I +-I-++ ++++ ..... -
Preliminary experiments directed at purification of the 
protective antigen by acetone, isoelectric and ammonium sul-
fate fractionation were negative, the somatic antigens preci-
pitating over a very broad range. This result ~was not alto-
gether unexpected as sonic lysates are frequentl7 not amenable 
to purification by precipitation techniques. 
* Sonic disruption was carried out at the Haynes Memorial 
Hospital through the courtesy of Dr. Louis Weinstein. 
Sodium Desoxycholate Lysate 
Lysis of agar grown !• Eestis was also carried out by 
treatment with sodium desoxycholate. One hundred Roux bot-
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tles containing beef heart infusion agar with o.Ol% cysteine 
added were heavily seeded with a 24 hour broth culture of 
!• pestis strain All22 and incubated for three days at 28 to 
32 c. (This temperature was selected to keep the production 
of envelope antigen at a minimum). 20 ml of saline were added 
to each bottle and the growth scraped off the surface of the 
agar with the aid of glass beads. The total volume was appro-
ximately 1500 ml. Sodium desoxycholate was added to a con-
centration of 0.5 per cent and the mixture allowed to remain 
at room temperature for 24 hours. The cell debris was re-
moved by centrifugation at 10~000 rpm for 30 minutes in a 
Servall angle centrifuge, Model SSIA. The supernatant was 
dialyzed against distilled water in the cold (3 C :i::. 2)~ con-
centrated by perevaporation at room temperature and lyoPhilized. 
This procedure resulted in the liberation of some 50 
per cent of the dry weight of the cells. (The crude extract 
was heavily contaminated with agar so the true yield may be 
somewhat lower). 
Fractionation of the crude desoxycholate lysate was 
carried out with acetone. Six grams of the crude lysate were 
dissolved in 350 cc of o.l5 M NaCl~ the solution brought to 
3 C and cold acetone added to 33 per cent concentration. 
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After standing in the cold for 24 hours the precipitate was 
removed by centrifugation at 2500 rpm. The supernatant was 
brought to 50 per cent acetone concentration and the resultant 
precipitate removed as above. The majority of the remaining 
acetone precipitable material was obtained by increasing the 
acetone concentration to 66 per cent. Each of these fractions 
was reprecipitated three times between the indicated acetone 
concentrations, dial7zed and lyophilized. The yields are 
presented below. 
Fraction 
0 to 33 
33 to 50 
50 to 65 
Yield 
1.07 g 
.970 g 
.630 g 
Per cent of Crude Lysate 
18 
16 
11 
Table V presents the results of guinea pig protection 
tests using the crude l7sate and the acetone fractions as 
immunogens. The crude lysate and the 0 to 33, and 33 to 50 
per cent acetone fractions were effective prophylactics when 
administered in adjuvant in the dose of .os mg. Since the 50 
to 65 per cent acetone fraction was not expected to protect at 
this low level, it was given only in the dose of 0.5 mg. In 
this amount it was protective also. It is quite clearly demon-
strated from these results that acetone fractionation was not 
effective in separating the protective principle from the crude 
lysate. 
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Casein Hydrolysate LYsate 
The observation was made by Engleaberg (7) that after 
six to seven days' growth of l• pestis in CHMG shake cultures 
massive lysis of the organisms ocourreda The crude supernatant 
of these cultures contained both mouse and guinea pig protective 
antigens. He carried out a preliminary fractionation of this 
material with ammonium sulfate and found that the "guinea pig 
antigen" was concentrated in the 0 to 25 per cent saturated 
traction. During a four month period of research at the George 
Williams Hooper Foundation of the University of California, 
a study of the chemical, pnysical aad biologic properties of 
this ant~gen was carried out. 
The guinea pig protective fraction isolated by Englesberg 
contained 30 to 40 per cent Fraction I by serologic analysis. 
His entire. procedure was followed as outlined below in the 
hope of achieving a better separation. 
One l liter Erlenmeyer flask containing 250 ml of CHMG 
media was heavily seeded with the growth from a 24 hour CHMG 
agar alant of l• pestis strain All22. This seed culture was 
incubated at 30 C for 24 hours on a rotary shaking apparatus 
rotating at 150 rpm. Two ml of the growth from this flask 
were added to each of the flasks to be used and the entire 
batch placed on a large rotary shaker and rotated at 150 rpm 
for six days at 37 c. Turbidimetric analysis showed that ex-
tensive lysis had occurred at this time. After checking the 
growth in each flask for purity by Gram staining,the cultures 
were pooled and centrifuged at 7,000 rpm for 15 minutes in a 
Spinoo centrifuge using a No. 20 head. 
The clear supernatant was cooled to 3 C ~ 2 and brought 
to saturation with solid ammonium sulfate. After standing for 
24 hours in the cold the precipitate formed a compact cake on 
the surface of the fluid. This cake was removed and the preci-
pitate further concentrated by filtration through medium poro-
sity Salas sintered glass filters. After dialysis in the cold 
against distilled water until free of sulfate, the crude lysate 
was concentrated to approximately one fourth volume by pereva-
poration. 
Since some material had precipitated during dialysis, 
the pH of the solution was brought to 7.5 with NaOH and suffi" 
cient NaCl added to bring the concentration to 0.15 M. The dry 
weight of the material in solution was determined by drying a 
small portion and the concentration adjusted to 5 to 7 mg per ml. 
Fractionation of the lysate was carried out with neutralized 
(pH 7.0) ammonium sulfate, the entire procedure being done in 
the cold. 
Fractions were taken between 0 to 25, 25 to 33, 33 to 50 
and 50 to 65 per oent saturation of ammonium sulfate. The 0 to 
25 and the 25 to 33 per cent fractions were repreoipitated four 
times between these concentrations of salt. The yields of the 
dialyzed and lyophilized fractions are presented below. 
Fraction Dry Weight 
(~ saturated Yield 
ammonillll sulfate) 
0 to 25 3•0 g 
25 to 33_ .650 g 
33 to 50 .250 g 
50 to 65 .sso g 
65 to 100 .350 g 
Per cent of 
Crude Lysate 
44.1 
Per cent 
Fraction I* 
4 to 5 
90 to 100 
12 to 15 
1 to 2 
0 
* The serologic data on which these values are based are 
presented in Figure 4. 
The interesting aspect of these data is that the 0 to 25 
per cent fraction isolated here only contained four to five 
per cent Fraction I in contrast to the 30 to 40 per cent found 
by Englesberg. This discrepancy may have beeD due to tne fact 
that fractionation was carried out on non-lyophilized material, 
while dried lysate was used in previous fractionations. This 
possibility• however• was not subjected to test. 
The 25 to 33 per c~t 1:'raction was serologically identi-
cal to Fraction IA~ as described by Baker~~· (4). 
The purified 0 to 25 per cent fraction seems to be pro-
tein in nature. It contains 13.5 per cent nitrogen, gives a 
strong biuret reaction and does not react in the sensitive 
Molisoh test for carbohydrate. The high nitrogen content 
(13.5~) and the negative Molisch reaction precludes any appre-
ciable amount of carbohydrate. The ultraviolet absorption 
spectz-um (Figure 5) demonstrates the absence o:f nucleic acido 
The absorption peak at 280 mu indicates the presence of a 
after the onset of growth and much before massive lysis occur-
red. However, no quantitative estimate of the relative amounts 
of antigen present at these time intervals could be obtained 
from these extremely variable results. The degree ef protec-
tion obtained with the six day lysate was much lower than that 
of previous tests and would indicate that this particular 
group of animals was comparatively refractive to immunization. 
The purified 0 to 25 per cent fraction is an excellent 
antigen in rabbits. Three 5 mg doses given intravenously on 
successive days yielded a very reactive antiserum 5 days after 
the last dose. When the serum was available, a serologic ana-
lysis was undertaken to determine the actual amounts of this 
.. 
antigen present in the dried 2, 4, and 6 days lysates used 1n 
the above guinea pig protection tests. The surprising results 
presented in Figure 7 are very difficult to interpret. The 
2, 4, and 6 day supernatants reacted to a very minor extent 
with this serum. {The results were so close together they 
are grouped on the same line for clarity} • If the pure anti~ 
gen was present even in minimal concentration in the erude 
supernatants, the turbidity should have eventually reached 
that of the homologous reaction if enough of the crude material 
was added. This was not the case. The possible explanations 
for this are several. If the antiserum used contained anti• 
body against several of the antigens in the crude lysate, a 
series of closely spaced r~ctions might occur and the all 
over result would be a very low turbidity. This can be visua-
lized as presented below. 
Antigen concentration 
resultant turbidity 
- •• - individual reacting 
systems 
However, the serum does not react with any of the other ammo-
nium sulfate fractions isolated from the crude lysate so this 
possibility does not seem likely. 
In the crude state it is possible that the 0 to 25 per 
cent fraction is loosely as.sociated with another substance 
which might obscure the serologically reactive groups. On the 
chance that this may have been Fraction I, a portion of the 6 
day lysate was absorbed with Fraction I antibody. The results 
presented in Figure 7 indicate that remc:>val of the Fraction I 
from the crude 6 day lysate did 1ncreas•9 the activity o:f the 
lysate :for the 0 to 25 antiserum. Howe'ITer, this increase was 
not enough to account for all o:f the 0 ~to 25 per cent fraction 
present in the crude material (44% by weight) and the reaction 
still did not reach the turbid! ty obtaiJ:led with the pure anti-
gen. Thus, some other inhibitory system must be operative in 
the crude lysate. 
It was found that the 0 to 25 per cent fraction reacted 
very well with a somatic antiserum prepared in rabbits accor• 
ding to the method of Bhatnager (5). ~le antigen used to 
produce this serwa was a 3 day agar cul1rure of !• pestis strain 
Yreka, boiled for lt hours. This procedure destroys the enve-
lepe antigen and the antisera so prepared did not react with 
Fraction I. Sohfttze (36) and Bhatnager (5) claim that the 
antibody present in such a serum is directed against the heat 
stable somatic antigens of the plague bacillus. Thus, the 
reaction or the 0 to 25 per cent rractic:m w1 th this serum 
characterizes it as one of this group of somatic antigens. 
Relation of the Phenol Antigen to Other !• Pestis Antigens 
The significance of the phenol antigen in the mosaic of 
plague antigens still remains somewhat C)bscure~ While the 
purified antigen is of excellent antigenicity in rabbits, it 
reacts only slightly with Lederle or S~1ibb antiplague globu-
lin. On the other hand, it reacted ve~r well with a hyper-
i~une !• pestis All22 serum. This would indicate that the 
isolated phenol antigen is not readily available as an antigen 
in the intact cell. The commercial sera were prepared in 
rabbits with only six or nine injections and would not be ex-
pected to contain antibody against the minor plague antigens. 
As has already been pointed out, the long term i~zation 
in the case of the All22 rabbit serum would tend to produce 
antibody directed against these same minor antigens. 
In contrast to this, antisera prepared in rabbits against 
the purified phenol antigen reacted well with various other 
antigenic preparations from !• pestis. A few of the results 
are presented below. 
Antigen Dilution (in thousands) 
Antigen 
Crude de-
sox;rcho-
1 2 4 8 16 32 64 128 Col 
late ly-
sate -/- -1--1-
33% ace• 
tone Frac-
tion of 
desoxycho-
late ly-
sate -/--1- -/--/--1- -/--/--1--/- -/--/- -1--1-· -/- -1--f- -1- -1--/- -1- -
SO% ace-
tone Frac-
tion of 
desoxycho-
late ly• 
sate + 
Sonic ly-
sate of 
+ 
residue -1--/--1--/- N.D. -1--1--/--1-
+-I-
N.D. 
-1--/- Jrl.D • :i:. -
The extent of the reaction of the phenol antisera with 
the crude desoxyeholate lysate is indicated by the data in 
Table VII and Figure 8. It is evident from these quantitative 
data that absorption ot the crude deso~rcholate lysate with 
antibody directed against the pure phen•ol antigen removed a 
large percentage of the serologically active material from 
that lysate. It should be kept in mind that the antiserum 
used here was Squibb g1obulin which reacted only slightly with 
the phenol antigen. 
While antibody directed against the purified phenol anti-
gen reacted well with extracts of agar grown organisms, it did 
-
not react at all w1 th the CHMG lysate oJ:o with any fractions 
of that lysate. Treatment of these fra~;}tions with 90% phenol 
did not liberate the antigen. Extraction of the cell debris 
from a six day CHMG shake culture, howe·ver, did .free a small 
amount of the active material. Thus, the phenol antigen was 
still attached to the stroma of the bacilli even after lysis 
had C!>Ccurred. 
49. 
The possibility that the pnenol antigen was derived from 
the media was submitted to test. Treatiment of beef heart in-
fusion agar with 90% phenol did not produce any of the antigen, 
and the agar medium did not react with Phenol antisera. 
Passive Protection of the Guinea Pig 
There has been considerable debate in the literature 
{see Introduction) as to the efficacy of hypertmmune plague 
--
antisera in passive protection of the guinea pig. Several ex-
periments were undertaken to determine whether any antiserum, 
if given in large enough doses, will protect this animal. It 
was also of interest to determine whether absorption of the 
antibody directed against the envelope antigen would remove 
any protective ability a serum might possess. 
Tables VIII and IX present the results of two passive 
protection experiments using two different vials of the same 
batch of Squibb antiplague globulin. The maximum protection 
obtained was 50 per cent in the first experiment and only 12.5 
per cent in the second. However, the average survival time 
after challenge in the latter experiment was considerably 
so. 
lengthened (16 days). Absorption of these sera with Fraction 
I seemed to remove the slight protective power they possessed. 
Although the indication is very strong that the antibody di-
rected against Fraction I was responsible for the protective 
activity of these sera in guinea pigs, the low level of pro-
tection achieved with the unabsorbed sera makes it difficult 
to place any great stress on these results. 
The "somatic• serum used in these experiments was pre-
pared according to the method of Bhatnager as described pre-
viously. It contained little or no Fraction I antibody and 
was completely non protective for mice . When given in doses 
o~ 5 or 10 oo t4is serum protected some 30 per cent of the 
animal s and lengthened the time of survival of those that 
died (Tables VIII and IX). 
The guinea pig and monkey sera used here were from ani-
mals that had survived a challenge dose of virulent !• pestis. 
These sera when given in the massive dose of 10 co protected 
only 20 and 30 per cent of the animals respectively. The sur-
vival time was also slightly increased. 
The best results were obtained with two hyperimmune rabbit 
sera. These rabbits were first immunized with killed organisms 
and then hyperimmunized with repeated doses of living virulent 
!• pestis strains 195/P and 111. Both of these sera showed 
excellent protection, the 111 serum imparting a more solid immu-
nity. Although the protection rate wi·th the 195/P serum was 
only 40 per cent the average survival t ime of those guinea pigs 
that died was greatly increased (21.1 days). 
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Discussion 
The studies outlined in the introduction seemed to indi-
cate that the antigen in !• pestis respcmsible for guinea pig 
protection was different from the ant1gc9n capable of protec-
ting mice, rats and monkeys. While the purified envelope an-
tigen was of excellent immunogenic value in the latter group 
of animals, it was completely devoid of protective activity 
in the guinea pig. On the other hand, ·t;he residue, essentially 
devoid of water soluble antigen, proteo·ted guinea pigs when ad-
ministered in very small doses. This ilnplied that the somatic 
portion of the bacillus contained this guinea pig antigen.. The 
data obtained in this investigation to some extent elucidate 
the nature of these somatic antigens and gives some evidence 
as to their biologic significance. 
This differentiation of water sol·uble envelope antigen 
and insoluble residue antigen in !• pes·~ deserves some comment. 
It was consistently observed that repeated aqueous extraction 
of plague bacilli, until the extracts nc:> longer reacted with 
an envelope antiserum, did not remove all of the surface anti-
gen. Extraction, by Chemical means, of these thoroughly aque-
ous extracted bacilli invariably removed a considerable amount 
of envelope antigen. These observations may indicate that 
Fraction I as defined serologically is found in both an outer 
aliae layer, easily soluble in physiological saline and in an 
inner layer more tenaciously held to the cell. The findings 
- I" 
of Amies {2) would tend to support this observation. He was 
very emphatic in stating that extraction with saline does not 
remove the entire envelope as demonstrated by India ink pre-
parations. This fact should be born in mind when discussing 
the biologic attributes of the residue. It is not devoid of 
envelope antigen and should not be considered as representative 
of the somatic portion of the plague bacillus. Further evi-
dence for this is given by unpublished data of Meyer and asso-
ciates who found that residue while of excellent immunogenic 
value in the guinea pig invariably gave rise to envelope anti-
body in these animals. 
Before discussing the broader implications of the data 
presented here, the variability of the guinea pig test should 
be emphasized. It has always been the policy of the group at 
the Hooper Foundation of the Uhiversity of California where 
these tests were run, to repeat guinea pig protection tests at 
least three times. The variability is such that even a 50 per 
cent difference in protection may not be significant in any 
one experiment. Many of the fractions described in this in-
vestigation were tested only once. In ·these easea a survival 
rate of 70 to 90 per cent was considered indicative of protec-
tion while a 0 to 20 per cent survival was considered negative 
or questionable. Anything in between m~st be repeated to 
achieve significance. Because of this variability no attempt 
was made to quantitate the results on the basis of LDso or 
MLD determinations. 
The concept of a somatic antigen in !• pestis was first 
set forth by Sch6tze (36). However, he did not attempt to 
-· . purify these substances and what he tel~ed somatic antigen 
was merely a crude preparation contain:i.ng a number of plague 
antigens with the relatively labile envelope antigens destroyed 
by heat. Thus, he was not able to directly test the efficacy 
of the somatic material in anima~ protection, although he 
compiled a mass of indirect data which clearly defines the 
envelope antigen as the protective substance in mice and rats. 
The original hypothesis as to the presence o~ a somatie 
grouping in !• ,Eestis similar to the somatic antigens of the 
Gram negative enteric group has proven erroneous. The classi-
cal methods of extracting these antigens (diethylene glycol, 
glycerol, pyridine) failed to remove a similar substance fran 
plague bacilli. This agrees with the findings of Girard (10) 
who was unable to extract a glucolipid antigen using the tri-
chloracetic method of Boivin and Mesrabeau. Furthermore, the 
substances extracted by other means, presumably from the soma 
of the bacillus, were chemically dissimilar to the somatic 
antigens. 
Two of this heterogeneous group of somatic antigens have 
been isolated in relatively pure state. The purified pnenol 
antigen, a protein polysacCharide complex is of no prophylactic 
power in the guinea pig. The fact that it reacts well with 
hyperimmune plague sera and not with more specific sera attests 
to its minor role as an antigen in the intact plague cell. 
The 0 to 25 per cent saturated an~onium sulfate fraction 
derived from CHMG shake cultures, seemed to be of much greater 
biolegic significance. This fraction i.n the crude state was 
of excellent immunogenic value in the guinea pig. The question 
then arises as to whether this degree of protection can be as-
cribed to the portion of the antigen derived from the soma of 
the bacillus or whether the 30 to 40 per cent envelope antigen 
present is responsible for this activity. It was originally 
thought that this envelope material might represent the less 
soluble fraction discussed earlier. On more careful fractiona-
tion it was possible to isolate the 0 to 25 per cent ammonium 
sulfate fraction with less than 5 per cent contaminating Frac-
tion I. Unfortunately the critical ani.mal test with this 
material was not conclusive, but the indication was that re-
moval of envelope material decreased the protective value of 
the preparation. 
Thus, the problem of which plague antigen or combination 
of antigens is responsible for proteet:!.on of the guinea pig 
still remains obscure. The possibilities are three fold: 
1. The envelope antigen alone may be required. Although 
t~s antigen as isolated and purified according to Baker ~ al. 
(4) is non protective, another substance with the same sero-
logic reactivity but of different :Phys:!.cal characteristics may 
be of importance. This again brings to mind the insoluble 
portion of the envelope still clinging to the residue after 
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thorough aqueous extraction. The evidence for the existence 
of such a substance in protective extracts, however, is lacking. 
2. One of the somatic antigens alone may be needed; per-
haps the 0 to 25 per cent fraction. This possibility is being 
subjected to further tests. Since it j_s well established that 
phagocytosis is the main defense of thE~ host animal against 
plague infection, it is difficult to conceive of an antigen 
buried beneath an extensive capsular layer being significant 
in protection. Yet, as discussed below,' the elaboration of 
antibody appears to be of secondary importance as an immunity 
mechanism in the gllinea pig. A speeif1.c increased activity 
of the phagocytic system in response to this somatic antigen 
may be of much greater significance. 
3. The guinea pig may need both envelope and somatic 
antigens for the production of a solid immunity. Vfuile this 
theory fits the observed facts and cann.ot be ruled out, it 
seemed unnecessarily complicated. Yet the only preparations 
producing a good immunity in this animal have always contained 
both these antigens. The preliminazy serologic evidence that 
the 0 to 25 per cent fraction may exist as a complex with the 
envelope antigen further supports this hypothesis. If this 
hypothetical complex exists, most of the perplexing body of 
facts concerning guinea pig immunity to plague will be clari-
fied. 
The failure of antiplague globulin to protect the guinea 
pig when given in doses of 50 to 375 mouse PD5o casts serious 
doubt on the effieacy of antibody alone in protecting this 
animal against infection. It is true 1;hat administration 
of potent rabbit antisera in massive aMounts will protect 
some 80 per cent of the animals,but tbi.s amount of antibody 
cannot be demonstrated in the actively immunized guinea pig. 
The fact that minute amounts of residue will immunize the 
guinea pig without the production of large amounts of anti-
body (although antibody is always present) also points up 
this .fact. A possible answer to this (iilemma is that not 
Qnly is antibody required but that an "immune" macrophage 
system may also be involved• A more rapid mobilization o.f 
hyperactive pnagoeytic cells at the portal o.f entry of the 
invading bacillus .. followed by localization o.f the infection 
and effective removal of the organisms may be a .function of 
this immune cellular system. Antibody~, in this case, would 
be of secondary importance. '!'his point; of view is supported 
by Jawetz and Meyer (14) who found some evidence for this 
in phagocytosis studies. This then is another basic dif-
ference in the response to plague infeotion of the mouse, 
which can be protected with minute amotmts of antibody 1 and 
of the guinea pig. Quantitative studies to determine whether 
this increased cellular response exists are technically ver.r 
difficult to carry out- but would be oj~ the greatest signi-
ficance in elucidating the dynamics of infection and resis-
tance to plague in the guinea pig. 
Summa£l 
1. Extraction of residue with 50% aqueous diethylene glycol, 
diethylene glycol and glycerol released an insignificant 
amount of serologically active material from the bacilli. 
ss. 
2. 50% aqueous pyridine extraction liberated some 15 per cent 
of the dry weight of the residue, but the extract was of low 
immunogenic value in the guinea pig. 
3. A protein polysaccharide complex was extracted fran the 
residue with 90% aqueous pnenol and was obtained in relatively 
pure form by fractionation at 33% acetone concentration. Al-
though this material was highly immunogenic in the rabbit it 
was of no prophylactic value in the guinea pig. 
4• Sonic disruption of the residue liberated the guinea pig 
protective antigen, but attempts to purify this substance 
were unsuccessful. 
s. Lfsis of agar grown Pasteurella pestis strain All22 with 
o.s% sodium desoxycholate yielded an extract of high immuno-
genic value for the guinea pig. The protective material pre-
cipitated over a broad range of acetone concentration and 
could not be purified by this method. 
6. An antigen of high immunogenic value in the guinea pig 
was removed from the supernatant of 6 day CHMG shake cultures 
by precipitation with ammonium sulfate between 0 to .25 satus 
ration. Repeated fractionation to remove the envelope antigen 
contai ned in this fraction seemed to decrease the effective-
ness of the preparation. Preliminary serologic evidence was 
obtained that this material in part existed in the crude ly-
sate in association with the envelope antigen. 
?. Massive amounts of antibody were required to passively 
protect the guinea pig against plague j~nfeetian. This may 
point to an immune cellular defense mechanism as the primary 
manifestation of immunity against plagt1e in the guinea pig. 
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T.A:BLE I 
Illlll11lllogenic Activity of Various Plague Extracts in Guinea l-igs 
Antigen Dose Survivors/Total 
Crude P71"idine extract, aqueous •• s ,, 
s.o 1/' 
Cruie pyridine extract, in adjuvant o.s 2/' 
s.o ,,, 
Sonic lysate of residue, aqueous o.s 2/e 
s.• 4/o 
Sonic lysate of residue, in 
adjuvant o.s 5/' 5. S/' 
Sonic qsate ef strain Bi-7', in 
adJuvant o.e5 8/11 
0.5 5/1 
J.rJriy vaccine • aqueous 1.5 m1 '/11 
.A:r:my ftecine • in adJuvant .os ml ,,, 
Controls 
-
0/10 
TABLE II 
Chellical .A.nalysis of the Phenol Antigen 
Nitrogen 
Phosphorus 
Reducing sugar 
Orcinol • total carbohydrate 
:Biuret test 
Electrophoretic mobility 
T.A:BLE III 
7 • .5% 
l.~ 
14.2% 
20.1% 
-l-
4.4o x l -S cm2/volt/sec 
61. 
~ntitative Precipitin Analysis of Phenol Antigen aDd its Homologous Antibody 
mg Antigen N Precipitate N* Antibody xs Antigen xs 
0.020 .z,so -1-
o.o4o .430.5 ~'-
o.o6o .,5l4o ::l::. 
o.oao • .531 
0.120 • .5380 .. - -i-
0.160 • .522 ... ~ + 
• All values represent the average of duplicate samples • 
TA:BLE IV 
Immtlll.Ogenic Activity of the Phenol J.ntigen in Guinea Pigs 
Antigen 
~urified. phenol antigen. aqueous 
Purified phenol antigen. in adjuvant 
Crude phenol antigen, aqueous 
Crude phenol antigen, in adJuvant 
Fraction I, in adjuvant 
Fraction I and pure phenol antigen, 
aqueous 
Fraction I aDd pure phenol antigen, 
in adjuvant 
Phenol residue, in adjuvant 
Cutter residue, aqueous 
Cutter residue. in adjuvant 
Arrsr:i vaccine, aqueous 
Controls 
Dose in :mg 
0.5 
5.0 
o.os 
0.5 
0.5 
5.0 
0.5 
5.0 
5.0 
s.o (2.5 mg of each) 
s.a (2.5 mg of each) 
o.os 
&.5 
5.0 
o.os 
o.s 
5.0 
0.05 ml 
Sunivors/!rota.l 
1/10 
1/6 
o/6 
2/6 
2/6 
1/~ 
0/6 
1/6 
6/6 
8/lo 
6/' 
5/.5 
3/6 
o/1o 
~. 
TA'BLEV 
Immunogenic Activity of the Sodium DesoX7cholate Lysate in Guinea Pigs* 
Crude l.y'sate 
Total Dose in mg 
o.o; 
o.; 
0 to 3)% acetone fraction of l.y'sate 0.15 
o.; 
33 to 5&% acetone fraction of l.y'sate e.o; 
o.; 
50 to "% acetone fraction of l.y'sate 0.5 
Cutter residue o. 5 
Controls 
* All antigens suspended. in adjuvant. 
Survivors/Total 
8/10 
'J/lG 
8/10 
8/10 
8/10 
o/lo 
T.A:BLE VI 
Immunogenic Activity of Fractions from the C~} Lysate in Guinea ~igs* 
Antigen 
0 to 25% (NH4)2S04 fraction 
<s% :rractil)n I) 
48 hour supernatant from CBMG culture 
'6 hour supernatant from cmn culture 
144 hour supernatant from CRH} culture 
Cutter vaccine 
Controls 
• All ant igens suspended in adjuvant. 
Total Dose in mg 
0.025 
.os 
0.25 
o.s 
5.0 
o.oo2 
o.o1 
o.os 
0.002 
o.o1 
o.os 
o.oo2 
o.ol 
o.o5 
0.002 
o.o1 
o.05 
o.os ml 
Survivl3rs/Total 
17/1, 
7/8 
1,/2 
lJ/16 
6/8 
0/1 
J/' 
J/' 
7/lo 
.5/10 
.5/10 
':f./10 
4/10 
4/10 
6/l 
2/10 
5/10 
8/10 
0/10 
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U.13LE VII 
~titative Precipitin Analysis of Orude .Deso~eholate Lysate vs. Squibb 
Antipla.gu.e Globul~n *• *II• 
Antigen Nitrogen 
in mg 
.177 
.237 
.333 
.472 
• .534 
·''.5 
1.18 
1.80 
Precipitate Nitrogen 
in mg 
• 80 
.124 
.208 
.3.52 
.410 
.451 
.515 
.• ,564 
.631 
.6.54 
.664 
.622 
~.5.36 
Deso~eholate Lysate Absorbed with Phenol Serum ·rs. Squibb Antip1ague Globulin 
.,368 
.612 
.1.$7 
.237 
* Figures corrected for 1 cc of a 1/5 di~ution of globu1in. 
** All nitrogen values represent an average of duplicate determinations. 
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!A.BLE VIII 
Passive Protection of Guinea Pigs with Various Plague Antisera* 
Serum Dose Survivors/Total Per Cent Average 
Su.rvivors Survival 
in D~s 
Squibb gl bulin 50 mouse PDso 4/10 4o a. a 
250 mouse PD50 5/10 50 7.4 
Squibb globulin 
absorbed with 
Fraction a•• 50 mouse PD51 0/10 7.8 
250 mouse PD50 2/10 20 8.4 
Somatic serllll 5 cc 2/6 33 '·7 
Controls 0/10 0 6.8 
• All serum administered 24 hours before challenge • 
** This serum was non protective in mice. The 6ose given is based on the 
unabsorbed globulin. 
TABLE IX 
Passive Protection of Guinea Pigs with Vaz·ious Plague Antisera 
Serum Dose Survivors/'l!otal Per Cent Average 
SurTiTal Survival 
i,n Dy:s 
Squibb globulin 75 mouse PD50 1/10 10 8.2 
375 mouse PD50 1/8 12.5 16.o 
Squibb globulin 
absorbed with 
Fraction IA* 75 mouse PD56 0/10 0 7., 
'375 mouse PD50 0/10 0 '·2 
Rabbi t - 1,5/P 10 cc ** 4/10 40 21.1 
Rabbit- 111 10 cc 8/10 80 11.0 
Convalescent 
monkey 10 ce '3/10 'JO 11.8 
Convalescent 
guinea pig 10 ce 2/10 20 1').4 
Somatic lG, ec '3/10 '30 1~.1 
Controls 0/10 0 ?.2 
* !his serum was non protective in mice. !he doae given was based on the 
unabsorbed globulin. 
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** ~ose sera given in 10 ce amounts were ad.minishred in 5 cc doses 24 hours 
before challenge followed by 5 ce 2 hours before. 
Figure 1 
Electrophoretic Patterns of Purified Phenol Antigen 
Ascending ~oUDdar,y Descending !oundar,v 
Time • .52 min. 
Ascending Boundar.y Descending ~oundar,y 
Time - 111 min. 
Antigen concentration - 1.~ 
Veronal buffer pH 8.6; ionic strength e.l 
Mobility - 4.40 x 1 -J cm2/volt/sec 
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'70o 
Antibody nitrogen determined by difference. 
Precipitate nitrogen - antigen nitrogen = antibody N 
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0-.25 SAT. (NH4)2S04 FRACTION 
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Figure 6 
Electrophoretic Patterns f the Purified 0 to .25 Saturated Ammonium Sulfate 
Fraction fl"om the OBMG Lysate 
Asce:cding .:Boundary Descending .:Boundary 
Time ... 103 min. 
Antigen concentration ~ 1.~ 
Veronal buffer pE 8.6; ionic strength 0.10 
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